Curis, Inc. Overview
CRIS market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
CRIS price chart · 1M
- O
- 0.775000
- H
- 0.909900
- L
- 0.772100
- C
- 0.887700
- Vol
- 7,522.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $0.78
- Previous Close
- $0.85
- Day High
- $0.91
- Day Low
- $0.77
- 52 Week High
- $28.60
- 52 Week Low
- $0.36
- 7 Day Return
- +45.05%
- 30 Day Return
- +19.93%
- 90 Day Return
- -74.71%
- 1 Year Return
- -96.90%
- Daily Notional Volume
- $6.7K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$11.52 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.66 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -80.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.33 – $29.80 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $7.4M · P/B 2.34 · P/S 0.79.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
8-K filing — CURIS INC (CRIS)SEC EDGAR ·
Lift Therapeutics Appoints Daniel Passeri as Chief Executive OfficerGlobenewswire Inc ·